1. Гельминтные инфекции, передаваемые через почву. Информационный бюллетень ВОЗ №366, май 2014 г. Женева: Всемирная организация здравоохранения, 2014.  [Soil-borne helminth infections. Information WHO Bulletin No. 366, May 2014 Geneva: World Health Organization, 2014 (In Russ.)]. http://www.who.int/mediacentre/factsheets/fs366/ru/. 
2. Паразитарные болезни человека (протозоозы и гельминтозы). Руководство для врачей. Под ред. В.П. Сергиева, Ю.В. Лобзина, С.С. Козлова. 3-е изд. СПб.: Фолиант, 2016 [Human parasitic diseases (protozoan and helminthiasis). A guide for doctors. Ed. VP Sergiev, YuV Lobzin, 
SS. Kozlov. 3rd ed. Saint Petersburg, Foliant; 2016 (In Russ.)].
3. Рамочная программа контроля и профилактики геогельминтозов в Европейском регионе ВОЗ, 2016–2020 гг. Копенгаген: Европейское региональное бюро ВОЗ, 2016 [Framework for the Control and Prevention of Geohelminthiasis in the WHO European Region 2016–2020. Copenhagen: WHO Regional Office for Europe, 2016. (In Russ.)]. uro.who.int/ru/publications/abstracts/framework-for-control-and-prevention-of-soil-transmitted-helminthiases-in-the-who-european-region-20162020-2016
4. Плиева А.М., Айсханов С.К. Паразиты – как возможная основа развития онкологических заболеваний. Теория и практика паразитарных болезней животных. 2011;12 [Plieva AM, Ajshanov SK. Parazity – kak vozmozhnaja osnova razvitija onkologicheskih zabolevanij. Teorija i praktika parazitarnyh boleznej zhivotnyh. 2011;12 (In Russ.)]. https://cyberleninka.ru/article/n/parazity-kak-vozmozhnaya-osnova-razvitiya-onkologicheskih-zaboleva...
5. De Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-15. doi: 10.1016/S1470-2045(12)70137-7
6. Рабочая группа МАИР по оценке канцерогенных рисков для людей. Биологические агенты. Обзор человеческих канцерогенов. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441 [Rabochaja gruppa MAIR po ocenke kancerogennyh riskov dlja ljudej. Biologicheskie agenty. Obzor chelovecheskih kancerogenov. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441 (In Russ.)].
7. Fried B, Reddy A, Mayer D. Helminths in human carcinogenesis. Cancer Lett. 2011;305(2):239-49. doi: 10.1016/j.canlet.2010.07.008
8. Vennervald BJ, Polman K. Helminths and malignancy. Parasite Immunol. 2009;31(11):686-96. doi: 10.1111/j.1365-3024.2009.01163.x
9. Machicado C, Marcos LA. Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis: A systematic review. Inter J Cancer. 2016;138(12):2915-21. doi: 10.1002/ijc.30028
10. Molyneux EM, Rochford R, Griffin B, et al. Burkitt's lymphoma. Lancet. 2012;379(9822):1234-44. doi: 10.1016/S0140-6736(11)61177-X
11. Thorley-Lawson D, Deitsch KW, Duca KA, Torgbor C. The Link between Plasmodium falciparum Malaria and Endemic Burkitt's Lymphoma-New Insight into a 50-Year-Old Enigma. PLoS Pathog. 2016;12(1):e1005331-e. doi: 10.1371/journal.ppat.1005331
12. Robbiani DF, Deroubaix S, Feldhahn N, et al. Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma. Cell. 2015;162(4):27-37. doi: 10.1016/j.cell.2015.07.019
13. Torgbor C, Awuah P, Deitsch K, et al. A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis. PLoS Pathog. 2014;10(5):e1004170. doi: 10.1371/journal.ppat.1004170
14. Montes M, Sawhney C, Barros N. Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis. 2010;23(5):500-4. doi: 10.1097/QCO.0b013e32833df718
15. Gabet A-S, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene. 2000;19:4954. doi: 10.1038/sj.onc.1203870
16. Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Par Immunol. 2004;26(11-12):487-97. doi: 10.1111/j.0141-9838.2004.00726.x
17. Fulbright LE, Ellermann M, Arthur JC. The microbiome and the hallmarks of cancer. PLoS Pathog. 2017;13(9):e1006480. doi: 10.1371/journal.ppat
18. Champer M, Wong A, Champer J, et al. The role of the vaginal microbiome in gynaecological cancer.BJOG: Inter J Obstet Gynaecol. 2018;125(3):309-15. doi: 10.1111/1471-0528.14631
19. Garrett WS. Cancer and the microbiota. Science (New York, NY). 2015;348(6230):80-6. doi: 10.1126/science.aaa4972
20. Leung JM, Graham AL, Knowles SCL. Parasite-Microbiota Interactions With the Vertebrate Gut: Synthesis Through an Ecological Lens. Front Microbiol. 2018;9:843. doi: 10.3389/fmicb.2018.00843
21. Berry A, Moné H, Iriart X, et al. Schistosomiasis haematobium, Corsica, France. Emerg Infect Dis. 2014;20(9)6:1595-7. doi: 10.3201/eid2009.140928
22. Engels D, Chitsulo L, Montresor A, Savioli L. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Tropica. 2002;82(2):139-46. doi: 10.1016/s0001-706x(02)00045-1
23. IARC. Biological agents. Volume 100B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441.
24. Adebayo AS, Survayanshi M, Bhute S, et al. The microbiome in urogenital schistosomiasis and induced bladder pathologies. PLoS Negl Trop Dis. 2017;11(8):e0005826. doi: 10.1371/journal.pntd.0005826
25. Ajibola O, Rowan AD, Ogedengbe CO, et al. Urogenital schistosomiasis is associated with signatures of microbiome dysbiosis in Nigerian adolescents. Sci Rep. 2019;9(1):829. doi: 10.1038/s41598-018-36709-1
26. Hsiao A, Toy T, Seo HJ, Marks F. Interaction between Salmonella and Schistosomiasis: A Review. PLoS Pathog. 2016;12(12):e1005928. doi: 10.1371/journal.ppat.1005928
27. Van Tong H, Brindley PJ, Meyer CG, Velavan TP. Par Infect Carcinogen Hum Malign. EBioMedicine. 2016;15:12-23. doi: 10.1016/j.ebiom.2016.11.034
28. Chng KR, Chan SH, Ng AHQ, et al. Tissue microbiome profiling identifies an enrichment of specific enteric bacteria In Opisthorchis viverrini associated cholangiocarcinoma. EBioMedicine. 2016 Jun;8:195-202. doi: 10.1016/j.ebiom.2016.04.034
29. Deenonpoe R, Chomvarin C, Pairojkul C, et al. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter. APJCP. 2015;16(5):1751-8. doi: 10.7314/apjcp.2015.16.5.1751
30. Dangtakot R, Pinlaor S, Itthitaetrakool U, et al. Coinfection with Helicobacter pylori and Opisthorchis viverrini Enhances the Severity of Hepatobiliary Abnormalities in Hamsters. Infect Immun. 2017;85(4):e00009-17. doi: 10.1128/IAI.00009-17
31. Deenonpoe R, Mairiang E, Mairiang P, et al. Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease. Sci Rep. 2017;7:42744. doi: 10.1038/srep42744
32. Plieskatt JL, Deenonpoe R, Mulvenna JP, et al. Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J. 2013;27(11):4572-84. doi: 10.1096/fj.13-232751
33. Fernández-Presas AM, Padilla-Noriega L, Becker I, et al. Enveloped and non-enveloped viral-like particles in Trypanosoma cruzi epimastigotes. Rev Inst Med Trop. 2017;59:e46-e. doi: 10.1590/S1678-9946201759046
34. Nibert ML, Woods KM, Upton SJ, Ghabrial SA. Cryspovirus: a new genus of protozoan viruses in the family Partitiviridae. Arch Virol. 2009;154(12):1959-65. doi: 10.1007/s00705-009-0513-7
35. Springer WT, Johnson J, Reid WM. Transmission of histomoniasis with male Heterakis gallinarum (Nematoda). Parasitol. 2009;59(2):401-5. doi: 10.1017/S0031182000082378
36. White EC, Houlden A, Bancroft AJ, et al. Manipulation of host and parasite microbiotas: Survival strategies during chronic nematode infection. Sci Adv. 2018;4(3):eaap7399. doi: 10.1126/sciadv.aap7399
37. Abou-Zied A, El-Beltagy T, Tantawy H, et al. Studies on the genomic association between schistosomiasis and hepatitis C virus infection. Clin Cancer Invest J. 2015;4(3):318-22. doi: 10.4103/2278-0513.151937
38. McNulty SN, Tort JF, Rinaldi G, et al. Genomes of Fasciola hepatica from the Americas Reveal Colonization with Neorickettsia Endobacteria Related to the Agents of Potomac Horse and Human Sennetsu Fevers. PLoS Genet. 2017;13(1):e1006537-e. doi: 10.1371/journal.pgen.1006537
39. Dheilly NM, Bolnick D, Bordenstein SR, et al. Parasite Microbiome Project: Systematic investigation of microbiome dynamics within and across parasite-host interactions. mSystems. 2017;2(4).
40. Dheilly NM, Ewald PW, Brindley PJ, et al. Parasite-microbe-host interactions and cancer risk. PLoS Pathog. 2019 Aug 15;15(8):e1007912. doi: 10.1371/journal.ppat.1007912
41. Oikonomopoulou K, Brinc D, Kyriacou K, Diamandis EP. Infection and cancer: revaluation of the hygiene hypothesis. Clin Cancer Res. 2013;19(11):2834-41. doi: 10.1158/1078-0432.CCR-12-3661
42. Atayde VD, Jasiulionis MG, Cortez M, Yoshida N. A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells. Melanoma Res. 2008;18(3):172-83. doi: 10.1097/CMR.0b013e3282feeaab
43. Shirzad H, Khorami S, Soozangar N, et al. Toxoplasma gondii but not Leishmania major or Trichomonas vaginalis decreases cell proliferation and increases cell death on fibrosarcoma cancer cells in culture medium. WJV. 201;2(2):105. doi: 10.4236/wjv.2012.22014
44. Yousofi Darani H, Soozangar N, Khorami S, et al. Hydatid cyst protoscolices induce cell death in WEHI-164 fibrosarcoma cells and inhibit the proliferation of baby hamster kidney fibroblasts in vitro. J Parasitol Res. 2012;2012:304183. doi: 10.1155/2012/304183
45. Akgul H, Tez M, Unal AE, et al. Echinococcus against cancer: why not? Cancer. 2003;98(9):1999-2000. doi: 10.1002/cncr.11752
46. Tez S, Tez M. Echinococcus and cancer: unsolved mystery. Parasite Immunol. 2015;37(8):426. doi: 10.1111/pim.12201
47. Turhan N, Esendagli G, Ozkayar O, et al. Co-existence of Echinococcus granulosus infection and cancer metastasis in the liver correlates with reduced Th1 immune responses. Parasite Immunol. 2015;37(1):16-22. doi: 10.1111/pim.12152
48. Oikonomopoulou K, Yu H, Wang Z, et al. Association between Echinococcus granulosus infection and cancer risk – a pilot study in Cyprus. Clin Chem Lab Med. 2016;54(12):1955-61. doi: 10.1515/cclm-2016-0125
49. Ferreira S, Fernandes R, Botelho MC. Fasciola hepatica extract induces cell death of mammalian cells. Antiinfect Agents. 2018;16:144-6. doi: 10.2174/1570180815666180531102555
50. Fernandes R, Alves H, Botelho MC. The cancer hygiene hypothesis: from theory to therapeutic helminths. Curr Cancer Ther Rev. 2019. doi: 10.2174/1573394714666181003143717

________________________________________________

1. Soil-borne helminth infections. Information WHO Bulletin No. 366, May 2014 Geneva: World Health Organization, 2014 (In Russ.)
 http://www.who.int/mediacentre/factsheets/fs366/ru/. 
2. Human parasitic diseases (protozoan and helminthiasis). A guide for doctors. Ed. VP Sergiev, YuV Lobzin, SS. Kozlov. 3rd ed. Saint Petersburg, Foliant; 2016 (In Russ.)
3. Framework for the Control and Prevention of Geohelminthiasis in the WHO European Region 2016–2020. Copenhagen: WHO Regional Office for Europe, 2016. (In Russ.)
uro.who.int/ru/publications/abstracts/framework-for-control-and-prevention-of-soil-transmitted-helminthiases-in-the-who-european-region-20162020-2016
4. Plieva AM, Ajshanov SK. Parazity – kak vozmozhnaja osnova razvitija onkologicheskih zabolevanij. Teorija i praktika parazitarnyh boleznej zhivotnyh. 2011;12 (In Russ.)
 https://cyberleninka.ru/article/n/parazity-kak-vozmozhnaya-osnova-razvitiya-onkologicheskih-zaboleva...
5. De Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-15. doi: 10.1016/S1470-2045(12)70137-7
6. Rabochaja gruppa MAIR po ocenke kancerogennyh riskov dlja ljudej. Biologicheskie agenty. Obzor chelovecheskih kancerogenov. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441 (In Russ.)
7. Fried B, Reddy A, Mayer D. Helminths in human carcinogenesis. Cancer Lett. 2011;305(2):239-49. doi: 10.1016/j.canlet.2010.07.008
8. Vennervald BJ, Polman K. Helminths and malignancy. Parasite Immunol. 2009;31(11):686-96. doi: 10.1111/j.1365-3024.2009.01163.x
9. Machicado C, Marcos LA. Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis: A systematic review. Inter J Cancer. 2016;138(12):2915-21. doi: 10.1002/ijc.30028
10. Molyneux EM, Rochford R, Griffin B, et al. Burkitt's lymphoma. Lancet. 2012;379(9822):1234-44. doi: 10.1016/S0140-6736(11)61177-X
11. Thorley-Lawson D, Deitsch KW, Duca KA, Torgbor C. The Link between Plasmodium falciparum Malaria and Endemic Burkitt's Lymphoma-New Insight into a 50-Year-Old Enigma. PLoS Pathog. 2016;12(1):e1005331-e. doi: 10.1371/journal.ppat.1005331
12. Robbiani DF, Deroubaix S, Feldhahn N, et al. Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma. Cell. 2015;162(4):27-37. doi: 10.1016/j.cell.2015.07.019
13. Torgbor C, Awuah P, Deitsch K, et al. A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis. PLoS Pathog. 2014;10(5):e1004170. doi: 10.1371/journal.ppat.1004170
14. Montes M, Sawhney C, Barros N. Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis. 2010;23(5):500-4. doi: 10.1097/QCO.0b013e32833df718
15. Gabet A-S, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene. 2000;19:4954. doi: 10.1038/sj.onc.1203870
16. Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Par Immunol. 2004;26(11-12):487-97. doi: 10.1111/j.0141-9838.2004.00726.x
17. Fulbright LE, Ellermann M, Arthur JC. The microbiome and the hallmarks of cancer. PLoS Pathog. 2017;13(9):e1006480. doi: 10.1371/journal.ppat
18. Champer M, Wong A, Champer J, et al. The role of the vaginal microbiome in gynaecological cancer.BJOG: Inter J Obstet Gynaecol. 2018;125(3):309-15. doi: 10.1111/1471-0528.14631
19. Garrett WS. Cancer and the microbiota. Science (New York, NY). 2015;348(6230):80-6. doi: 10.1126/science.aaa4972
20. Leung JM, Graham AL, Knowles SCL. Parasite-Microbiota Interactions With the Vertebrate Gut: Synthesis Through an Ecological Lens. Front Microbiol. 2018;9:843. doi: 10.3389/fmicb.2018.00843
21. Berry A, Moné H, Iriart X, et al. Schistosomiasis haematobium, Corsica, France. Emerg Infect Dis. 2014;20(9)6:1595-7. doi: 10.3201/eid2009.140928
22. Engels D, Chitsulo L, Montresor A, Savioli L. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Tropica. 2002;82(2):139-46. doi: 10.1016/s0001-706x(02)00045-1
23. IARC. Biological agents. Volume 100B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441.
24. Adebayo AS, Survayanshi M, Bhute S, et al. The microbiome in urogenital schistosomiasis and induced bladder pathologies. PLoS Negl Trop Dis. 2017;11(8):e0005826. doi: 10.1371/journal.pntd.0005826
25. Ajibola O, Rowan AD, Ogedengbe CO, et al. Urogenital schistosomiasis is associated with signatures of microbiome dysbiosis in Nigerian adolescents. Sci Rep. 2019;9(1):829. doi: 10.1038/s41598-018-36709-1
26. Hsiao A, Toy T, Seo HJ, Marks F. Interaction between Salmonella and Schistosomiasis: A Review. PLoS Pathog. 2016;12(12):e1005928. doi: 10.1371/journal.ppat.1005928
27. Van Tong H, Brindley PJ, Meyer CG, Velavan TP. Par Infect Carcinogen Hum Malign. EBioMedicine. 2016;15:12-23. doi: 10.1016/j.ebiom.2016.11.034
28. Chng KR, Chan SH, Ng AHQ, et al. Tissue microbiome profiling identifies an enrichment of specific enteric bacteria In Opisthorchis viverrini associated cholangiocarcinoma. EBioMedicine. 2016 Jun;8:195-202. doi: 10.1016/j.ebiom.2016.04.034
29. Deenonpoe R, Chomvarin C, Pairojkul C, et al. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter. APJCP. 2015;16(5):1751-8. doi: 10.7314/apjcp.2015.16.5.1751
30. Dangtakot R, Pinlaor S, Itthitaetrakool U, et al. Coinfection with Helicobacter pylori and Opisthorchis viverrini Enhances the Severity of Hepatobiliary Abnormalities in Hamsters. Infect Immun. 2017;85(4):e00009-17. doi: 10.1128/IAI.00009-17
31. Deenonpoe R, Mairiang E, Mairiang P, et al. Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease. Sci Rep. 2017;7:42744. doi: 10.1038/srep42744
32. Plieskatt JL, Deenonpoe R, Mulvenna JP, et al. Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J. 2013;27(11):4572-84. doi: 10.1096/fj.13-232751
33. Fernández-Presas AM, Padilla-Noriega L, Becker I, et al. Enveloped and non-enveloped viral-like particles in Trypanosoma cruzi epimastigotes. Rev Inst Med Trop. 2017;59:e46-e. doi: 10.1590/S1678-9946201759046
34. Nibert ML, Woods KM, Upton SJ, Ghabrial SA. Cryspovirus: a new genus of protozoan viruses in the family Partitiviridae. Arch Virol. 2009;154(12):1959-65. doi: 10.1007/s00705-009-0513-7
35. Springer WT, Johnson J, Reid WM. Transmission of histomoniasis with male Heterakis gallinarum (Nematoda). Parasitol. 2009;59(2):401-5. doi: 10.1017/S0031182000082378
36. White EC, Houlden A, Bancroft AJ, et al. Manipulation of host and parasite microbiotas: Survival strategies during chronic nematode infection. Sci Adv. 2018;4(3):eaap7399. doi: 10.1126/sciadv.aap7399
37. Abou-Zied A, El-Beltagy T, Tantawy H, et al. Studies on the genomic association between schistosomiasis and hepatitis C virus infection. Clin Cancer Invest J. 2015;4(3):318-22. doi: 10.4103/2278-0513.151937
38. McNulty SN, Tort JF, Rinaldi G, et al. Genomes of Fasciola hepatica from the Americas Reveal Colonization with Neorickettsia Endobacteria Related to the Agents of Potomac Horse and Human Sennetsu Fevers. PLoS Genet. 2017;13(1):e1006537-e. doi: 10.1371/journal.pgen.1006537
39. Dheilly NM, Bolnick D, Bordenstein SR, et al. Parasite Microbiome Project: Systematic investigation of microbiome dynamics within and across parasite-host interactions. mSystems. 2017;2(4).
40. Dheilly NM, Ewald PW, Brindley PJ, et al. Parasite-microbe-host interactions and cancer risk. PLoS Pathog. 2019 Aug 15;15(8):e1007912. doi: 10.1371/journal.ppat.1007912
41. Oikonomopoulou K, Brinc D, Kyriacou K, Diamandis EP. Infection and cancer: revaluation of the hygiene hypothesis. Clin Cancer Res. 2013;19(11):2834-41. doi: 10.1158/1078-0432.CCR-12-3661
42. Atayde VD, Jasiulionis MG, Cortez M, Yoshida N. A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells. Melanoma Res. 2008;18(3):172-83. doi: 10.1097/CMR.0b013e3282feeaab
43. Shirzad H, Khorami S, Soozangar N, et al. Toxoplasma gondii but not Leishmania major or Trichomonas vaginalis decreases cell proliferation and increases cell death on fibrosarcoma cancer cells in culture medium. WJV. 201;2(2):105. doi: 10.4236/wjv.2012.22014
44. Yousofi Darani H, Soozangar N, Khorami S, et al. Hydatid cyst protoscolices induce cell death in WEHI-164 fibrosarcoma cells and inhibit the proliferation of baby hamster kidney fibroblasts in vitro. J Parasitol Res. 2012;2012:304183. doi: 10.1155/2012/304183
45. Akgul H, Tez M, Unal AE, et al. Echinococcus against cancer: why not? Cancer. 2003;98(9):1999-2000. doi: 10.1002/cncr.11752
46. Tez S, Tez M. Echinococcus and cancer: unsolved mystery. Parasite Immunol. 2015;37(8):426. doi: 10.1111/pim.12201
47. Turhan N, Esendagli G, Ozkayar O, et al. Co-existence of Echinococcus granulosus infection and cancer metastasis in the liver correlates with reduced Th1 immune responses. Parasite Immunol. 2015;37(1):16-22. doi: 10.1111/pim.12152
48. Oikonomopoulou K, Yu H, Wang Z, et al. Association between Echinococcus granulosus infection and cancer risk – a pilot study in Cyprus. Clin Chem Lab Med. 2016;54(12):1955-61. doi: 10.1515/cclm-2016-0125
49. Ferreira S, Fernandes R, Botelho MC. Fasciola hepatica extract induces cell death of mammalian cells. Antiinfect Agents. 2018;16:144-6. doi: 10.2174/1570180815666180531102555
50. Fernandes R, Alves H, Botelho MC. The cancer hygiene hypothesis: from theory to therapeutic helminths. Curr Cancer Ther Rev. 2019. doi: 10.2174/1573394714666181003143717

Х.Г. Омарова, Н.И. Алешина, Ж.Б. Понежева, А.В. Горелов, В.В. Малеев, В.Г. Акимкин

ФБУН «Центральный научно-исследовательский институт эпидемиологии» Роспотребнадзора, Москва, Россия

________________________________________________

Kh.G. Omarova, N.I. Aleshina, Zh.B. Ponezhevа, A.V. Gorelov, V.V. Maleev, V.G. Akimkin

Central Research Institute of Epidemiology, Moscow, Russia